VG2D PHARMA
SIREN 984188870
What the register says about VG2D PHARMA
VG2D PHARMA is registered under SIREN number 984188870. Its registered office is located at 2 Avenue Robert Schuman, 51100 Reims. The company was founded on 29/01/2024. It declares that it operates in the Recherche-développement en biotechnologie sector. It is currently listed as active in the national business register.
BODACC has published 5 notices concerning it, the most recent dated 23/10/2026. An account filing makes public the annual accounts submitted to the court registry: it confirms that accounting records exist and have been filed, nothing more. It says nothing about revenue, profit, or the commercial health of the company. A modification signals a declared change: management, registered office, activity, or share capital.
One director is published in the register. They are WILD (KERMADI).
Identity : VG2D PHARMA
VG2D PHARMA
- SIREN
- 984188870
- Head office SIRET
- 98418887000013
- Legal form
- SAS (société par actions simplifiée)
- NAF code
- 72.11Z · Recherche-développement en biotechnologie
- Address
- 2 Avenue Robert Schuman, 51100 Reims
- Creation date
- 01/29/2024
- Status
- Active
- VAT
- FR15984188870
- Filing
- 07/05/2026
- Closing
- 12/31/2025
Recent notices (5)
- 10/23/2026Collective proceduresVG2D PHARMA(principal)
- 07/05/2026Account depositsVG2D PHARMA(principal)
- 04/08/2025Account depositsVG2D PHARMA(principal)
- 04/23/2024Miscellaneous changesVG2D PHARMA(principal)
- 02/18/2024CreationsVG2D PHARMA(principal)
Web presence : VG2D PHARMA
The company's official website, its networks and online contact details.
Web presence : VG2D PHARMA
Recent notices : VG2D PHARMA
The BODACC notices published for this company.
Directors : VG2D PHARMA
The people who run or have run the company.
Relations : VG2D PHARMA
The relationship graph: linked notices, people and companies.
Public contracts : VG2D PHARMA
The public contracts won by the company.
No won public contract found for this company
FAQ & filings : VG2D PHARMA
Frequently asked questions and the company's filing history.